Therapeutic inhibition of SGK1 suppresses colorectal cancer

Colorectal cancer (CRC) is one of the leading causes of death worldwide. Thus, the development of new therapeutic targets for CRC treatment is urgently needed. SGK1 is involved in various cellular activities, and its dysregulation can result in multiple cancers. However, little is known about its ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xuchun, Lan, Chunling, Jiao, Guanming, Fu, Wencheng, Long, Xuesha, An, Yu, Wang, Kejin, Zhou, Jinzhe, Chen, Ting, Li, Yongqin, Xu, Jiahong, Huang, Qi, Xu, Bin, Xiao, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704191/
https://www.ncbi.nlm.nih.gov/pubmed/29170478
http://dx.doi.org/10.1038/emm.2017.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704191/
https://www.ncbi.nlm.nih.gov/pubmed/29170478
http://dx.doi.org/10.1038/emm.2017.184

Ejemplares similares